Replies to post #59298 on Biotech Values

[genisi]

Just a clarification:
Copaxone is protected by 4 formulation patents listed in the FDA's Orange Book expiring in 2014 (not composition of matter patent).
Its H-W and Orphan Drug exclusivities expired 2001 and 2003 respectively.